The list ranks drugs by their annual cost for a typical course of therapy and are based on the drugs’ list prices.
The 10 most expensive drugs in the U.S., according to GoodRx:
- Zolgensma (Novartis) — $2,125,000
- Myalept (Amryt Pharma) — $855,678
- Luxturna (Spark Therapeutics) — $850,000
- Folotyn (Acrotech Biopharma) — $779,067
- Soliris (Alexion Pharmaceuticals) — $678,392
- Blincyto (Amgen) — $672,968
- Ravicti (Horizon Therapeutics) — $664,092
- Lumizyme (Sanofi) — $643,243
- Actimmune (Horizon Therapeutics) — $633,325
- Takhzyro (Takeda Pharmaceuticals) — $591,035
More articles on pharmacy:
CMS launches Part D plan to lower insulin costs
15 largest pharmacies in the US
Trump sends list of drug-pricing policy proposals to Capitol Hill
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.